Back

Cerebello-Basal Ganglia Functional Network Integration in Psychosis

Jackson, T. B.; Damme, K. S. F.; Mittal, V. A.; Bernard, J. A.

2022-11-13 neuroscience
10.1101/2022.11.12.516285 bioRxiv
Show abstract

Psychotic disorders are conceptualized as brain-network diseases and both the cerebellum (CB) and basal ganglia (BG) are implicated in widely used conceptual models. Previous research has focused on these structures and their respective circuits as distinct, however, both are functionally and anatomically connected to each other and to cortical networks via domain-specific, topographically organized thalamo-cortical loops. Currently, it is unclear how CB-BG network dysfunction may play a mechanistic role in the course of psychosis; however, network global efficiency (GE), a measure of functional integration, is a novel approach that aims to represent cognitive and motor CB-BG network (CCBN, MCBN, respectively) connectivity in cross- sectional groups of healthy control (HC), clinical high-risk (CHR), early course psychosis (ECP), and chronic psychosis (CP) participants. We compared network GE between groups and inspected individual differences in CCBN- and MCBN-GE as it relates to group membership and to psychosis symptoms. We also associated CB-BG network GE with cortical network GE. Results indicated that CCBN-GE was associated with cognitive dysfunction and lower in CHR individuals, compared to HC and CP; while MCBN was associated with negative psychosis symptoms. Last, we detailed CB-BG associations with sensory, motor, default mode, and salience networks across groups, with group effects demonstrating complex differences within the ECP group. Findings indicating that CB-BG network dysfunction may play an important role in early pathogenesis and authors argue for CB-BG dysfunction to be analyzed from a network perspective. Future work is needed however to incorporate this approach into our understanding of psychosis.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Schizophrenia Research
29 papers in training set
Top 0.1%
38.3%
2
NeuroImage: Clinical
132 papers in training set
Top 0.6%
6.9%
3
Translational Psychiatry
219 papers in training set
Top 0.9%
6.5%
50% of probability mass above
4
Scientific Reports
3102 papers in training set
Top 35%
3.6%
5
Psychiatry Research: Neuroimaging
16 papers in training set
Top 0.1%
3.6%
6
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 0.6%
2.6%
7
Psychological Medicine
74 papers in training set
Top 0.7%
2.6%
8
Progress in Neuro-Psychopharmacology and Biological Psychiatry
36 papers in training set
Top 0.3%
2.1%
9
Biological Psychiatry
119 papers in training set
Top 2%
1.7%
10
Brain Imaging and Behavior
14 papers in training set
Top 0.1%
1.7%
11
Schizophrenia Bulletin
29 papers in training set
Top 0.4%
1.7%
12
Molecular Psychiatry
242 papers in training set
Top 2%
1.5%
13
Neurobiology of Disease
134 papers in training set
Top 3%
1.5%
14
Frontiers in Psychiatry
83 papers in training set
Top 3%
1.0%
15
Human Brain Mapping
295 papers in training set
Top 4%
0.9%
16
Neuroscience
88 papers in training set
Top 2%
0.9%
17
PLOS ONE
4510 papers in training set
Top 64%
0.9%
18
Brain Sciences
52 papers in training set
Top 2%
0.8%
19
Psychiatry Research
35 papers in training set
Top 1%
0.8%
20
Neuroscience Letters
28 papers in training set
Top 1.0%
0.8%
21
eneuro
389 papers in training set
Top 9%
0.8%
22
Frontiers in Human Neuroscience
67 papers in training set
Top 3%
0.7%
23
Schizophrenia
19 papers in training set
Top 0.4%
0.7%
24
European Journal of Neuroscience
168 papers in training set
Top 2%
0.7%
25
Neuropsychologia
77 papers in training set
Top 1%
0.7%
26
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 1%
0.5%
27
Brain Communications
147 papers in training set
Top 4%
0.5%
28
Neuropsychopharmacology
134 papers in training set
Top 3%
0.5%
29
International Journal of Molecular Sciences
453 papers in training set
Top 19%
0.5%